NCT05982743

Randomized Controlled Trial of Lactobacillus Casei Strain Shirota Fermented Milk for Alleviating Hard Stools in Vietnam

Name: Clinical Trial NCT05982743
Creator: Yakult Honsha Co., LTD
Keywords: Constipation, Lactobacillus casei strain Shirota fermented milk, dietary supplement, clinical trial, Vietnam

A Pilot Study of Using Fermented Milk Containing Lactobacillus Casei Strain Shirota (LcS) in Some Constipated Adults Having High Prevalence of Hard Stools in Vietnam

Yakult Honsha Co., LTD·ClinicalTrials.gov·dietary supplementCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Constipation
Drug/Device/Intervention: Lactobacillus casei strain Shirota fermented milk
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Yakult Honsha Co., LTD
Location: Hanoi, Vietnam

Timeline & enrollment

Phase: N/A
Start date: May 11, 2022
End date: Mar 08, 2023
Enrollment: 51 participants

Primary outcome

Proportion of subjects that produce hard or lumpy stools (Bristol stool form scale (BS) score of 1 or 2) ≥ 25% of bowel movements

Summary

The objective of this study is to provide evidence supporting the efficacy of fermented milk containing Lactobacillus casei strain Shirota in alleviating hard or lumpy stools. A randomized, controlled trial has been designed on constipated adults with a high prevalence of hard stools in Vietnam.

ICD-10 classifications

ConstipationIrritable bowel syndrome with predominant constipation [IBS-C]Other laxativesPoisoning: Other laxativesOther functional intestinal disorders

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05982743
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05982743 through Pure Global AI's free database. This phase not specified trial is sponsored by Yakult Honsha Co., LTD and is currently Completed. The study focuses on Constipation. Target enrollment is 51 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.